Antidote co-owner Chin Loh is frustrated at how difficult it is for pharmacies to begin offering the COVID-19 vaccine
Eighteen months after New Zealand's first nationwide Alert Level 4 lockdown, Pharmacy Today reporters Jonathan Chilton-Towle and Anna Lee revisited, in a socially distanced way, pharmacy staff they interviewed last year to see how a year and a half has changed the pandemic landscape
When news of an Alert Level 4 lockdown broke, Chin Loh, co-owner of Dunedin's Antidote chain, closed two of its eight pharmacies, Antidote Octagon and
Linda Bryant discusses gout, a chronic long-term condition that is often associated with other diseases, and drug-related morbidity and mortality. As such, gout needs to be addressed holistically as part of the psychosocial medical model
Patients can no longer be started on funded selegiline. Patients who were on selegiline prior to 1 August 2021 will need their prescriptions endorsed to receive subsidised supplies. An alternative MAO-B inhibitor, rasagiline, may be a suitable agent for new patients or those transitioning from selegiline.
This resource provides a timeline for the changes and information about transitioning patients from selegiline. Advice on prescribing rasagiline is also included.